Global Medical REIT Hits New 52-Week Low at $30.03

Global Medical REIT, Inc., a microcap player in the realty sector, has recently reached a new 52-week low of USD 30.03 on November 4, 2025. This decline marks a significant moment for the company, which has seen a remarkable one-year performance of 231.68%, significantly outpacing the S&P 500's 19.89% return during the same period.
Despite the recent price drop, Global Medical REIT has demonstrated strong long-term fundamental strength, with operating profits growing at a compound annual growth rate (CAGR) of 18.16%. The company has also reported a healthy annual growth rate of 13.90% in net sales. However, recent quarterly results have shown a decline in pre-tax profit and net profit, falling by 76.15% and 72.82%, respectively.

With a market capitalization of USD 554 million, Global Medical REIT maintains a price-to-earnings ratio of 48.00 and a dividend yield of 4.35%. The stock's price-to-book ratio stands at 1.10, indicating a valuation that is attractive compared to its peers. Institutional holdings are notably high at 75.96%, reflecting confidence from larger investors in the company's fundamentals.